DULAC EDWARD J III (EVP, Chief Financial Officer) sold 6.0% of their position (6.38K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $58.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2026ACC: 0001193125-26-006275
Officer· EVP, Chief Financial Officer
Since Mar 2026
-6.38K
Net shares
Net seller
$58.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.38K
Price / share
$9.21
Trade value
$58.75K
% of position
6.0%
1/5/2026
106.06K→99.68K
Total
Net shares
−6.38K
Net value
-$58.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | S · Sale | −6.38K | $9.21 | $58.75K | 6.0% | 106.06K | 99.68K |
| Total | −6.38K | -$58.75K | ||||||
Derivative Transactions0
No derivative transactions reported